Attached files
| file | filename |
|---|---|
| EX-32.2 - CERTIFICATION - Hoth Therapeutics, Inc. | f10q0321ex32-2_hoththerap.htm |
| EX-31.2 - CERTIFICATION - Hoth Therapeutics, Inc. | f10q0321ex31-2_hoththerap.htm |
| EX-31.1 - CERTIFICATION - Hoth Therapeutics, Inc. | f10q0321ex31-1_hoththerap.htm |
| 10-Q - QUARTERLY REPORT - Hoth Therapeutics, Inc. | f10q0321_hoththerap.htm |
Exhibit 32.1
Certification of Chief Executive Officer
Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Pursuant to 18 U.S.C. Section 1350,as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, Robb Knie, Chief Executive Officer of Hoth Therapeutics, Inc. (the “Company”), hereby certifies that based on the undersigned’s knowledge:
| 1. | The Company’s quarterly report on Form 10-Q for the period ended March 31, 2021 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: May 13, 2021 | /s/ Robb Knie |
| Robb Knie, | |
| Chief Executive Officer (Principal Executive Officer) |